References
- Kabat EA, Wu TT. Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains *. Ann N Y Acad Sci. 1971;190:382–21. doi:https://doi.org/10.1111/j.1749-6632.1971.tb13550.x.
- Bork P, Holm L, Sander C. The immunoglobulin fold. J Mol Biol. 1994;242:309–20. doi:https://doi.org/10.1006/jmbi.1994.1582.
- Lesk AM, Chothia C. Evolution of proteins formed by β-sheets: II. The core of the immunoglobulin domains. J Mol Biol. 1982;160:325–42. doi:https://doi.org/10.1016/0022-2836(82)90179-6.
- Lefranc M-P, Giudicelli V, Ginestoux C, Bodmer J, Müller W, Bontrop R, Lemaitre M, Malik A, Barbié V, Chaume D. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 1999;27:209–12. doi:https://doi.org/10.1093/nar/27.1.209.
- Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol. 1987;196:901–17. doi:https://doi.org/10.1016/0022-2836(87)90412-8.
- Tramontano A, Chothia C, Lesk AM. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins. J Mol Biol. 1990;215:175–82. doi:https://doi.org/10.1016/S0022-2836(05)80102-0.
- Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol. 1992;224:487–99. doi:https://doi.org/10.1016/0022-2836(92)91010-M.
- Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins11Edited by I. A. Wilson. J Mol Biol. 1997;273:927–48. doi:https://doi.org/10.1006/jmbi.1997.1354.
- Carter P, Presta LEN, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME, Shepard HM. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci. 1992;89:4285–89.
- Hsiao K, Bajorath J, Harris LJ. Humanization of 60.3, an anti-CD18 antibody; importance of the L2 loop. Protein Eng Des Sel. 1994;7:815–22. doi:https://doi.org/10.1093/protein/7.6.815.
- Krauss J, Arndt MAE, Zhu Z, Newton DL, BK V, Choudhry V, Darbha R, Ji X, NS C-L, MP D, et al. Impact of antibody framework residue V H −71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme. Br J Cancer. 2004;90:1863–70. doi:https://doi.org/10.1038/sj.bjc.6601759.
- Maruthachalam BV, El-Sayed A, Liu J, AR S, Hill W, MK A, Pastushok L, Fonge H, Barreto K, Geyer CR. A single-framework synthetic antibody library containing a combination of canonical and variable complementarity-determining regions. ChemBioChem. 2017;18:2247–59. doi:https://doi.org/10.1002/cbic.201700279.
- Teplyakov A, Obmolova G, Malia TJ, Raghunathan G, Martinez C, Fransson J, Edwards W, Connor J, Husovsky M, Beck H, et al. Structural insights into humanization of anti-tissue factor antibody 10H10. mAbs. 2018;10:269–77. doi:https://doi.org/10.1080/19420862.2017.1412026.
- Lehmann A, Wixted Josephine H F, Shapovalov MV, Roder H, Dunbrack RL, Robinson MK. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach. mAbs. 2015;1–14. doi:https://doi.org/10.1080/19420862.2015.1088618/6745–1071
- Meyder A, Nittinger E, Lange G, Klein R, Rarey M. Estimating electron density support for individual atoms and molecular fragments in X-ray structures. J Chem Inf Model. 2017;57:2437–47. doi:https://doi.org/10.1021/acs.jcim.7b00391.
- Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, Chen X, Longo NS, Louder M, McKee K, et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science. 2011;333:1593–602. doi:https://doi.org/10.1126/science.1207532.
- Zhou T, Zhu J, Wu X, Moquin S, Zhang B, Acharya P, Georgiev IS, Altae-Tran HR, Chuang G-Y, Joyce MG, et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity. 2013;39:245–58. doi:https://doi.org/10.1016/j.immuni.2013.04.012.
- Huang J, Kang BH, Ishida E, Zhou T, Griesman T, Sheng Z, Wu F, Doria-Rose NA, Zhang B, McKee K, et al. Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth. Immunity. 2016;45:1108–21. doi:https://doi.org/10.1016/j.immuni.2016.10.027.
- Rutten L, Lai Y-T, Blokland S, Truan D, Bisschop IJM, Strokappe NM, Koornneef A, Manen DV, Chuang GY, Farney SK, et al. A universal approach to optimize the folding and stability of prefusion-closed HIV-1 envelope trimers. Cell Rep. 2018;23:584–95. doi:https://doi.org/10.1016/j.celrep.2018.03.061.
- Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, Oliveira TYK, Pietzsch J, Fenyo D, Abadir A, Velinzon K, et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science. 2011;333:1633–37.
- Mouquet H, Scharf L, Euler Z, Liu Y, Eden C, Scheid JF, Halper-Stromberg A, Gnanapragasam PNP, Spencer DIR, Seaman MS, et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci. 2012;109:E3268–E3277. doi:https://doi.org/10.1073/pnas.1217207109.
- Klein F, Diskin R, Scheid JF, Gaebler C, Mouquet H, Georgiev IS, Pancera M, Zhou T, Incesu R-B, Fu BZ, et al. Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell. 2013;153:126–38. DOI:https://doi.org/10.1016/j.cell.2013.03.018.
- Julien JP, Sok D, Khayat R, Lee JH, Doores KJ, Walker LM, Ramos A, Diwanji DC, Pejchal R, Cupo A, et al. Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. PLoS Pathog. 2013;9:e1003342–e1003342. doi:https://doi.org/10.2210/pdb4jy4/pdb.
- Julien J-P, Cupo A, Sok D, Stanfield RL, Lyumkis D, Deller MC, Klasse P-J, Burton DR, Sanders RW, Moore JP, et al. Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer. Science. 2013;342:1477–83. doi:https://doi.org/10.1126/science.1245625.
- Scharf L, Scheid JF, Lee JH, West AP, Chen C, Gao H, Gnanapragasam PNP, Mares R, Seaman MS, Ward AB, et al. Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. Cell Rep. 2014;7:785–95. doi:https://doi.org/10.1016/j.celrep.2014.04.001.
- Garces F, Sok D, Kong L, McBride R, Kim HJ, Saye-Francisco KF, Julien J-P, Hua Y, Cupo A, Moore JP, et al. Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell. 2014;159:69–79. doi:https://doi.org/10.1016/j.cell.2014.09.009.
- Pancera M, Zhou T, Druz A, Georgiev IS, Soto C, Gorman J, Huang J, Acharya P, Chuang G-Y, Ofek G, et al. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature. 2014;514:455–61. doi:https://doi.org/10.1038/nature13808.
- Wu X, Zhang Z, Schramm CA, Joyce MG, Do Kwon Y, Zhou T, Sheng Z, Zhang B, O’Dell S, McKee K, et al. Maturation and diversity of the VRC01-antibody lineage over 15 years of chronic HIV-1 infection. Cell. 2015;161:470–85. doi:https://doi.org/10.1016/j.cell.2015.03.004.
- Scharf L, Wang H, Gao H, Chen S, McDowall AW, Bjorkman PJ. Broadly neutralizing antibody 8ANC195 recognizes closed and open states of HIV-1. Env Cell. 2015;162:1379–90. doi:https://doi.org/10.1016/j.cell.2015.08.035.
- Kong L, Torrents de la Peña A, Deller MC, Garces F, Sliepen K, Hua Y, Stanfield RL, Sanders RW, Wilson IA. Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer. Acta Crystallogr D Biol Crystallogr. 2015;71:2099–108. doi:https://doi.org/10.1107/S1399004715013917.
- Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, et al. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. Science. 2016;352:828–33. doi:https://doi.org/10.1126/science.aae0474.
- Davenport TM, Gorman J, Joyce MG, Zhou T, Soto C, Guttman M, Moquin S, Yang Y, Zhang B, Doria-Rose NA, et al. Somatic hypermutation-induced changes in the structure and dynamics of HIV-1 broadly neutralizing antibodies. Structure. 2016;24:1346–57. doi:https://doi.org/10.1016/j.str.2016.06.012.
- Steichen JM, Kulp DW, Tokatlian T, Escolano A, Dosenovic P, Stanfield RL, McCoy LE, Ozorowski G, Hu X, Kalyuzhniy O, et al. HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies. Immunity. 2016;45:483–96. doi:https://doi.org/10.1016/j.immuni.2016.08.016.
- Wang H, Cohen AA, Galimidi RP, Gristick HB, Jensen GJ, Bjorkman PJ. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop. Proc Natl Acad Sci. 2016;113:E7151–E7158. doi:https://doi.org/10.1073/pnas.1615939113.
- Pancera M, Lai Y-T, Bylund T, Druz A, Narpala S, O’Dell S, Schön A, Bailer RT, Chuang G-Y, Geng H, et al. Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529. Nat Chem Biol. 2017;13:1115–22. doi:https://doi.org/10.1038/nchembio.2460.
- Guenaga J, Garces F, Stanfield RL, Dubrovskaya V, Higgins B, Carrette B, Ward AB, Wilson IA, Wyatt RT. Glycine substitution at helix-to-coil transitions facilitates the structural determination of a stabilized subtype C HIV envelope glycoprotein. Immunity. 2017;46:792–803.e3. doi:https://doi.org/10.1016/j.immuni.2017.04.014.
- Chuang G-Y, Geng H, Pancera M, Xu K, Cheng C, Acharya P, Chambers M, Druz A, Tsybovsky Y, Wanninger TG, et al. Structure-based design of a soluble prefusion-closed HIV-1 env trimer with reduced CD4 affinity and improved immunogenicity. J Virol. 2017;91:e02268–16. doi:https://doi.org/10.1128/JVI.02268-16.
- Zhou T, Doria-Rose NA, Cheng C, GBE S-J, Chuang G-Y, Chambers M, Druz A, Geng H, McKee K, Kwon YD, et al. Quantification of the impact of the HIV-1-glycan shield on antibody elicitation. Cell Rep. 2017;19:719–32. doi:https://doi.org/10.1016/j.celrep.2017.04.013.
- Wang H, Gristick HB, Scharf L, West AP, Galimidi RP, Seaman MS, Freund NT, Nussenzweig MC, Bjorkman PJ. Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies. eLife. 2017;6:e27389. doi:https://doi.org/10.7554/eLife.27389.
- Medina-Ramírez M, Garces F, Escolano A, Skog P, SW T, ID M-S, AT M, Yasmeen A, A-J B, Ozorowski G, et al. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J Exp Med. 2017;214:2573–90. doi:https://doi.org/10.1084/jem.20161160.
- Sarkar A, Bale S, Behrens A-J, Kumar S, Sharma SK, Val N, Pallesen J, Irimia A, Diwanji DC, Stanfield RL, et al. Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer. Nat Commun. 2018;9:1–14. doi:https://doi.org/10.1038/s41467-018-04272-y.
- Moyo T, Ereño-Orbea J, Jacob RA, Pavillet CE, Kariuki SM, Tangie EN, Julien J-P, Dorfman JR. Molecular basis of unusually high neutralization resistance in tier 3 HIV-1 strain 253-11. J Virol. 2018;92:e02261–17. doi:https://doi.org/10.1128/JVI.02261-17.
- Xu K, Acharya P, Kong R, Cheng C, Chuang G-Y, Liu K, Louder MK, O’Dell S, Rawi R, Sastry M, et al. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Nat Med. 2018;24:857–67. doi:https://doi.org/10.1038/s41591-018-0042-6.
- Barnes CO, Gristick HB, Freund NT, Escolano A, Lyubimov AY, Hartweger H, West AP, Cohen AE, Nussenzweig MC, Bjorkman PJ. Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope. Nat Commun. 2018;9:1–12. doi:https://doi.org/10.1038/s41467-018-03632-y.
- Zhang P, Gorman J, Geng H, Liu Q, Lin Y, Tsybovsky Y, Go EP, Dey B, Andine T, Kwon A, et al. Interdomain stabilization impairs CD4 binding and improves immunogenicity of the HIV-1 envelope trimer. Cell Host Microbe. 2018;23:832–844.e6. doi:https://doi.org/10.1016/j.chom.2018.05.002.
- Bhiman JN, Anthony C, Doria-Rose NA, Karimanzira O, Schramm CA, Khoza T, Kitchin D, Botha G, Gorman J, Garrett NJ, et al. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat Med. 2015;21:1332–36. doi:https://doi.org/10.1038/nm.3963.
- Zhou T, Lynch RM, Chen L, Acharya P, Wu X, Doria-Rose NA, Joyce MG, Lingwood D, Soto C, Bailer RT, et al. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors. Cell. 2015;161:1280–92. doi:https://doi.org/10.1016/j.cell.2015.05.007.
- Liao H-X, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD, Fire AZ, Roskin KM, Schramm CA, Zhang Z, et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature. 2013;496:469–76. doi:https://doi.org/10.1038/nature12053.
- Schanz M, Liechti T, Zagordi O, Miho E, Reddy ST, Günthard HF, Trkola A, Huber M. High-throughput sequencing of human immunoglobulin variable regions with subtype identification. Plos One. 2014;9:e111726. doi:https://doi.org/10.1371/journal.pone.0111726.
- Soto C, Ofek G, Joyce MG, Zhang B, McKee K, Longo NS, Yang Y, Huang J, Parks R, Eudailey J, et al. Developmental pathway of the MPER-directed HIV-1-neutralizing antibody 10E8. Plos One. 2016;11:e0157409. doi:https://doi.org/10.1371/journal.pone.0157409.
- Zhu J, Wu X, Zhang B, McKee K, O’Dell S, Soto C, Zhou T, Casazza JP, Mullikin JC, Kwong PD, et al. De novo identification of VRC01 class HIV-1–neutralizing antibodies by next-generation sequencing of B-cell transcripts. Proc Natl Acad Sci U S A. 2013;110:E4088–E4097. doi:https://doi.org/10.1073/pnas.1306262110.
- Kepler TB, Liao H-X, Alam SM, Bhaskarabhatla R, Zhang R, Yandava C, Stewart S, Anasti K, Kelsoe G, Parks R, et al. Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies. Cell Host Microbe. 2014;16:304–13. doi:https://doi.org/10.1016/j.chom.2014.08.006.
- Ester M, Kriegel H-P, Sander J, Xu X A density-based algorithm for discovering clusters a density-based algorithm for discovering clusters in large spatial databases with noise. in Proceedings of the Second International Conference on Knowledge Discovery and Data Mining KDD’96. (Portland, Oregon: AAAI Press), 226–31. [Accessed February 1, 2017]. http://dl.acm.org/citation.cfm?id=3001460.3001507
- Wall JS, Gupta V, Wilkerson M, Schell M, Loris R, Adams P, Solomon A, Stevens F, Dealwis C. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vλ6 proteins. J Mol Recognit. 2004;17:323–31. doi:https://doi.org/10.1002/jmr.681.
- Hayward S. Peptide-plane flipping in proteins. Protein Sci. 2001;10:2219–27. doi:https://doi.org/10.1110/ps.23101.
- North B, Lehmann A, Dunbrack RL. A new clustering of antibody CDR loop conformations. J Mol Biol. 2011;406:228–56.
- Galson JD, Clutterbuck EA, Trück J, Ramasamy MN, Münz M, Fowler A, Cerundolo V, Pollard AJ, Lunter G, Kelly DF. BCR repertoire sequencing: different patterns of B cell activation after two Meningococcal vaccines. Immunol Cell Biol. 2015;93:885–95. doi:https://doi.org/10.1038/icb.2015.57.
- Ellebedy AH, Jackson KJL, Kissick HT, Nakaya HI, Davis CW, Roskin KM, McElroy AK, Oshansky CM, Elbein R, Thomas S, et al. Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat Immunol. 2016;17:1226–34. doi:https://doi.org/10.1038/ni.3533.
- Johnson EL, Doria-Rose NA, Gorman J, Bhiman JN, Schramm CA, Vu AQ, Law WH, Zhang B, Bekker V, Abdool Karim SS, et al. Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation. Nat Commun. 2018;9:1–13. doi:https://doi.org/10.1038/s41467-018-06424-6.
- Rubelt F, Bolen CR, McGuire HM, Heiden JAV, Gadala-Maria D, Levin M, Euskirchen G, Mamedov MR, Swan GE, Dekker CL, et al. Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cells. Nat Commun. 2016;7:1–12. doi:https://doi.org/10.1038/ncomms11112.
- Turchaninova MA, Davydov A, Britanova OV, Shugay M, Bikos V, Egorov ES, Kirgizova VI, Merzlyak EM, Staroverov DB, Bolotin DA, et al. High-quality full-length immunoglobulin profiling with unique molecular barcoding. Nat Protoc. 2016;11:1599–616. doi:https://doi.org/10.1038/nprot.2016.093.
- Vander Heiden JA, Stathopoulos P, Zhou JQ, Chen L, Gilbert TJ, Bolen CR, Barohn RJ, Dimachkie MM, Ciafaloni E, Broering TJ, et al. Dysregulation of B cell repertoire formation in myasthenia gravis patients revealed through deep sequencing. J Immunol Baltim Md 1950. 2017;198:1460–73. doi:https://doi.org/10.4049/jimmunol.1601415.
- Kirik U, Persson H, Levander F, Greiff L, Ohlin M. Antibody heavy chain variable domains of different germline gene origins diversify through different paths. Front Immunol. 2017:8. doi:https://doi.org/10.3389/fimmu.2017.01433.
- Modi V, Dunbrack RL. Defining a new nomenclature for the structures of active and inactive kinases. Proc Natl Acad Sci. 2019;116:6818–27. doi:https://doi.org/10.1073/pnas.1814279116.
- Shapovalov M, Vucetic S, Dunbrack RL. A new clustering and nomenclature for beta turns derived from high-resolution protein structures. PLoS Comput Biol. 2019;15:e1006844. doi:https://doi.org/10.1371/journal.pcbi.1006844.
- Adolf-Bryfogle J, Kalyuzhniy O, Kubitz M, Weitzner BD, Hu X, Adachi Y, Schief WR, Dunbrack RL. Rosetta antibody design (RAbD): a general framework for computational antibody design. bioRxiv. 2018:183350. doi:https://doi.org/10.1101/183350.
- Weitzner BD, Jeliazkov JR, Lyskov S, Marze N, Kuroda D, Frick R, Adolf-Bryfogle J, Biswas N, Dunbrack RL, Gray JJ. Modeling and docking antibody structures with Rosetta. Nat Protoc. 2017;12:401–16. doi:https://doi.org/10.1038/nprot.2016.180.
- Dunbar J, Krawczyk K, Leem J, Marks C, Nowak J, Regep C, Georges G, Kelm S, Popovic B, Deane CM. SAbPred: a structure-based antibody prediction server. Nucleic Acids Res. 2016;44:W474–W478. doi:https://doi.org/10.1093/nar/gkw361.
- Marcatili P, Rosi A, Tramontano A. PIGS: automatic prediction of antibody structures. Bioinformatics. 2008;24:1953–54. doi:https://doi.org/10.1093/bioinformatics/btn341.
- Adolf-Bryfogle J, Xu Q, North B, Lehmann A, Dunbrack RL. PyIgClassify: a database of antibody CDR structural classifications. Nucleic Acids Res. 2015;43:D432–D438.
- Honegger A, Plückthun AP. Yet Another Numbering Scheme for Immunoglobulin Variable Domains: An Automatic Modeling and Analysis Tool. Journal of Molecular Biology. 2001;309:657–670 3 doi:https://doi.org/10.1006/jmbi.2001.4662
- Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R, Kaufman K, Renfrew PD, Smith CA, Sheffler W, et al. ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol. 2011;487:545–74. doi:https://doi.org/10.1016/B978-0-12-381270-4.00019-6.
- Shrake A, Rupley JA. Environment and exposure to solvent of protein atoms. Lysozyme and insulin. J Mol Biol. 1973;79:351–71. doi:https://doi.org/10.1016/0022-2836(73)90011-9.
- Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Müller A, Nothman J, Louppe G, et al. Scikit-learn: machine Learning in Python. ArXiv E-Prints. 2012;1201:arXiv:1201.0490.
- Simpson GG. Notes on the measurement of faunal resemblance. Am J Sci. 1960;258:300–11.
- Kovaltsuk A, Leem J, Kelm S, Snowden J, Deane CM, Krawczyk K. Observed antibody space: a resource for data mining next-generation sequencing of antibody repertoires. J Immunol. 2018;201:2502–09. doi:https://doi.org/10.4049/jimmunol.1800708.
- Stewart JJ, Lee CY, Ibrahim S, Watts P, Shlomchik M, Weigert M, Litwin SA. Shannon entropy analysis of immunoglobulin and T cell receptor. Mol Immunol. 1997;34:1067–82. doi:https://doi.org/10.1016/S0161-5890(97)00130-2.
- Giudicelli V, Brochet X, Lefranc M-P. IMGT/V-QUEST: IMGT Standardized Analysis of the Immunoglobulin (IG) and T Cell Receptor (TR) Nucleotide Sequences. Cold Spring Harb Protoc. 2011;2011:pdb.prot5633. doi:https://doi.org/10.1101/pdb.prot5633.